All News

From coughs and colds to analgesics, pharmacists give their top two OTC brand recommendations in this exclusive Drug Topics survey.

CMS issues final rule for competitive acquisition program for DMEPOS suppliers

Comparative effectiveness research needed to find the best in drugs, devices, biologicals, and procedures to improve healthcare, contain costs

Drug Topics' exclusive OTC Recommendation Survey 2007 finds that R.Ph.s are providing more OTC recommendations and counseling than ever.

The use of intravenous (IV) syringes for non-IV applications such as enteral feedings poses many risks, especially for the pediatric and neonatal population which has a majority of their oral and enteral doses provided through a gastric tube. The Baxa Corporation recently announced the launch of a new educational campaign to make healthcare providers aware of these problems and offer solutions.

While persons with Medicare still are adjusting to 2007 plan changes and modifications to their coverage, Part D sponsors are preparing 2008 bids that are due in June.

CMS officials urge pharmacists to get NPI numbers and health plans to develop contingency plans.

Winn-Dixie named top pharmacy for MTM by Outcomes

The new 2007 update to the 2004 mucositis management guidelines has been published in the March issue of Cancer. New additions include the use of palifermin to prevent mucositis in high-dose chemotherapy with or without total body irradiation plus stem cell transplantation.

Merck has received FDA approval of combination drug Janumet, containing both sitagliptin and metformin. The new product utilizes three different mechanisms to improve glycemic control in type 2 diabetes.

Traditional facial moisturizers and skin lotions are passé to many observers of this field.

Which over-the-counter and health and beauty care brands accounted for the most dollar sales in drugstores, supermarkets, and mass-mercahndisers last year?

Duane Reade, a drugstore chain in metropolitan New York, and Together Rx Access, a free prescription savings program, have partnered to help eligible New Yorkers without health insurance gain access to prescription medicines.

A survey by Harris Interactive found that patients' lack of confidence in drug safety and their experiences with adverse reactions to prescribed medications leads to nonadherence.

The proposed bill would give responsibility for the nation's vaccine safety to an independent agency within the Department of Health & Human Services, removing most vaccine safety research from CDC.

Bill proposed in the California state senate would give licensed psychologists prescribing privileges.

According to a report from Families USA, Medicare Part D drug prices grew almost four times faster than inflation from April 2006 to April 2007.

A new company, PharmMD Solutions, has been launched to advocate use of medication therapy management for reducing medication-related health problems.

The Pediatric Influenza Immunization Coalition is an initiative of the National Foundation for Infectious Diseases (NFID) that aims to increase alarmingly low influenza immunization rates in U.S. children.

The study of 600 retail clinic users and 900 potential users found that strong referral networks are now forming among retail clinics and traditional healthcare systems operating around them.

The FDA has confirmed Mylan's current status of having the only approved ANDA for all strengths of amlodipine besylate, which is a generic version of Pfizer's Norvasc

Jaeger declared that the Senate must enact a clear, efficient, and abbreviated approval pathway to ensure timely access to biogenerics

GPhA declared that the availability of safe and effective generic versions of biopharmaceuticals, or biogenerics, could save the Medicare system billions of dollars annually.

A new report released by PhRMA said there are 219 medicines currently in clinical trials or under review by the FDA for use in children.

Healthcare professionals can now access emerging drug safety information via podcasts, according to the FDA.

The FDA has given the green light for a 12.5-mg dose of the long-acting injectable formulation of risperidone, Risperdal Consta, from Alkermes and Janssen.

The CtW Investment Group is urging fellow CVS/Caremark shareholders to withhold their votes from former Caremark directors.